Form 4: COMPASS Pathways Director Robert McQuade Granted 26,000 Share Options

COMPASS Pathways plc Director Robert McQuade was granted 26,000 share options with an exercise price of $4.52, aligning his interests with shareholders.

Summary

• Robert McQuade, a Director of COMPASS Pathways plc (CMPS), was granted 26,000 share options.
• The transaction date for this grant was June 12, 2025.
• Each option has an exercise price of $4.52.
• The options allow the holder to buy Ordinary Shares, which may be represented by American Depositary Shares (ADSs), with each ADS currently representing one Ordinary Share.
• The shares underlying these options will vest in full upon the earlier of (i) the first anniversary of the grant date (June 12, 2026) or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.
• The options have an expiration date of June 11, 2035.
• Following this transaction, Robert McQuade beneficially owns 26,000 derivative securities (share options).

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as the grant of options aligns director interests with shareholders, which is generally viewed favorably. It's a routine compensation event, not indicative of significant operational news.

Positives

• The grant of share options to a director, Robert McQuade, aligns his personal financial interests with the long-term performance and shareholder value creation of COMPASS Pathways plc.
• The options have a long expiration date (June 11, 2035), providing a significant window for potential value realization if the company's share price appreciates.

Future Outlook

The future outlook for Robert McQuade's ownership of these options is tied to the vesting schedule, which is expected to occur by the first anniversary of the grant date or the 2026 Annual General Meeting, and the long-term performance of COMPASS Pathways plc's share price relative to the $4.52 exercise price.

Industry Context

The grant of share options to directors is a common practice in the biotechnology and pharmaceutical industries, particularly for companies like COMPASS Pathways plc, which are often in development stages. This form of compensation is used to attract and retain talent, and to align the interests of management and directors with those of shareholders by incentivizing long-term growth and share price appreciation.

Comparison to Industry Standards

• Granting equity compensation, such as share options, to directors is a standard practice across publicly traded companies, including those in the biopharmaceutical sector like COMPASS Pathways plc.
• The vesting schedule, tied to a one-year anniversary or the next AGM, is typical for director equity grants, ensuring continued engagement and alignment.
• The long expiration period of the options (10 years) is also common for executive and director compensation, providing ample time for the company's strategic initiatives to mature and potentially increase share value.

Related Party Transactions

• The grant of share options to Robert McQuade, a director of COMPASS Pathways plc, constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant of options aims to align the director's interests with those of shareholders, potentially leading to decisions that enhance long-term shareholder value.
• Management: This type of compensation is a standard tool for incentivizing and retaining key management and board members.

Next Steps

• The share options will vest in full upon the earlier of June 12, 2026, or the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2026.
• Robert McQuade may choose to exercise these options at any time after vesting and before the expiration date of June 11, 2035, assuming the share price is above the exercise price of $4.52.

Key Dates

Keywords

COMPASS Pathways, CMPS, Share Options, Director Compensation, SEC Form 4, Insider Transaction, Equity Compensation, Derivative Securities, Corporate Governance